Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Little Girl Lip Syncs 'Girls Like You' With Daddy And It's The Cutest Thing Ever
Teacher Finds Messages On Her Student's Pencils
Couple's Maternity Shoot In A Pumpkin Patch Has A Terrifying Ending
Three Sisters Are Going As The Hocus Pocus Witches For Halloween
Police Officer's Heartfelt Plea Describes The Side Of The Job You Don't Read About In The News
US Embassy Accidentally Invites People To Cat Pajama Party
Little Girl Lip Syncs 'Girls Like You' With Daddy And It's The Cutest Thing Ever
The Incredible Moment This Man Finds His Dog In The Streets 3 Years After He Lost Him
Athlete With Cerebral Palsy Learns He's Been Signed By Nike
Werewolf? Man Films Enormous Wolf During Late Night Drive
Someone Added Hilarious Captions To An Argument Between A French Bulldog And Mom
